PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
09-May-2023 Global 2D Materials Market Report 2023: Growing Adoption of 2D Materials in Energy Storage Drives Growth - ResearchAndMarkets.com Businesswire
09-May-2023 Envision Pharma Group Announces Appointment of Dr. Deepti Sodhi Jaggi to Board of Directors Newswire
09-May-2023 Neuboron Medical Group and Xiamen Humanity Hospital Make ‘Grand Debut’ at Xiamen BNCT Tech Forum to Drive Clinical Application and New Drug Development Businesswire
09-May-2023 Emirates SkyCargo launches new bespoke solutions for Life Sciences and Healthcare Emirates SkyCargo
09-May-2023 Zion Pharma Announces Global Agreement with Roche to Develop and Commercialize a Blood Brain Barrier Penetrant Oral HER2 Tyrosine Kinase Inhibitor Businesswire
09-May-2023 Number of shares and voting rights of Innate Pharma as of May 1, 2023 Businesswire
09-May-2023 EUROAPI and Novéal sign CDMO agreement to advance cosmetic projects Businesswire
09-May-2023 FDA Accepts Application for Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO) Businesswire
09-May-2023 Positive Interim Data of BellaSeno’s Clinical Trial with Resorbable Breast and Chest Implants Reported at RACS 2023 BellaSeno GmbH
09-May-2023 Intuit QuickBooks Launches QuickBooks Online Accountant in More Than 170 Countries Around the World, Including Thailand Businesswire
09-May-2023 Ochre Bio to Participate in Upcoming Global Industry Conferences Businesswire
08-May-2023 Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Businesswire
08-May-2023 Fabrinet Announces Third Quarter Fiscal Year 2023 Financial Results Businesswire
08-May-2023 Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Conference Call and Webcast Today at 4:30 p.m. ET Businesswire
08-May-2023 Atara Biotherapeutics Announces First Quarter 2023 Financial Results and Operational Progress Businesswire
08-May-2023 Enanta Pharmaceuticals Reports Positive Topline Results from Phase 2 SPRINT Trial Evaluating EDP-235 in Standard Risk Patients with COVID-19 Businesswire
08-May-2023 Establishment Labs Reports Record First Quarter 2023 Financial Results Businesswire
08-May-2023 Cullgen Raises $40 Million in New Financing Led by AstraZeneca-CICC Fund Businesswire
08-May-2023 FCPS and Battelle Announce $50,000 in STEM Grants Businesswire
08-May-2023 Cultural Responsiveness Enhances Access to Care and Improves Health Outcomes Businesswire